One national master contract and budget template for all cancer trials
Contract negotiation between a hospital and a drug company often takes longer than the trial's first patient. A single pre-agreed contract and budget template, used by everyone, would cut months off opening a trial.
A government or national research body publishes a non-negotiable model clinical trial agreement (the UK's model agreements and Accelerated Clinical Trial Agreement are precedents) plus a standard per-procedure budget schedule. Sites and sponsors that adopt it skip legal negotiation; adopters are listed publicly and public funders require adoption. Extend the same to a standard data-sharing clause and a standard indemnity.
- Trials enrol too few, too slowly · Fewer than one in ten adults with cancer joins a trial. Trials close for lack of patients, not lack of ideas.
- Regulatory divergence between regions · Regulatory divergence means a drug approved in one country can take years to reach another, or never arrive.
Pages like this
not linked directly; found by shared links- IdeaOne clinical trial application accepted by regulators in every major region
Shares EU Clinical Trials Register / CTIS, ClinicalTrials.gov, Trials enrol too few, too slowly, Regulatory divergence between regions.
- IdeaPublish why patients were screened out of each trial
Shares EU Clinical Trials Register / CTIS, ClinicalTrials.gov, Trials enrol too few, too slowly.
- IdeaOne ethics approval and one consent form for a platform trial across countries
Shares EU Clinical Trials Register / CTIS, ClinicalTrials.gov, Regulatory divergence between regions.
- IdeaMutual recognition of ethics review across countries
Shares EU Clinical Trials Register / CTIS, Trials enrol too few, too slowly, Regulatory divergence between regions.
- IdeaDefault-inclusive eligibility: sponsors must justify every exclusion criterion
Shares ClinicalTrials.gov, Trials enrol too few, too slowly, National Cancer Institute (NIH).
- IdeaEvery patient is asked once at diagnosis whether researchers may contact them
Shares Trials enrol too few, too slowly, Cancer Research UK.
- IdeaPay investigators for finishing and publishing trials, not for enrolling patients
Shares EU Clinical Trials Register / CTIS, ClinicalTrials.gov, Trials enrol too few, too slowly.
- IdeaCommunity health workers and trusted local organisations paid to recruit for trials
Shares Trials enrol too few, too slowly, National Cancer Institute (NIH).